Microwave-accelerated preparation and analytical characterization of 5-ethoxy-N,N-dialkyl-[α,α,β,β-H4]- and [α,α,β,β-D4]-tryptamines

Drug Testing and Analysis

Volumn 3, Issue 9, 2011, Pages 597-608

  Tearavarich, Ruchanok ^a   Hahnvajanawong, Viwat ^b   Dempster, Nicola ^c   Daley, Paul F ^d   Cozzi, Nicholas V ^e   Brandt, Simon D ^c  

^a RAJAMANGALA UNIVERSITY OF TECHNOLOGY ISAN   (Thailand)

^b Khon Kaen University   (Thailand)

^c LIVERPOOL JOHN MOORES UNIVERSITY   (United Kingdom)

^d CALIFORNIA PACIFIC MEDICAL CENTER   (United States)

^e UNIVERSITY OF WISCONSIN SCHOOL OF MEDICINE AND PUBLIC HEALTH   (United States)

Author keywords

Clinical; Deuteration; Forensic; Mass spectrometry; Microwaves; Tryptamines

Indexed keywords

DEUTERIUM; FORENSIC SCIENCE; GAS CHROMATOGRAPHY; IONS; NUCLEAR MAGNETIC RESONANCE SPECTROSCOPY; SUPPLY CHAINS;

ANALYTICAL CHARACTERIZATION; BIOANALYTICAL; CLINICAL; DEUTERATED DERIVATIVES; DEUTERATIONS; DIVERSE RANGE; FORENSIC; INTERNAL STANDARDS; PROPERTY; TRYPTAMINES;

MASS SPECTROMETRY;

5 ETHOXY N ALLYL N CYCLOHEXYLTRYPTAMINE; 5 ETHOXY N ALLYL N CYCLOHEXYL[ALPHA,ALPHA,BETA,BETA DEXTRO 4]TRYPTAMINE; 5 ETHOXY N ETHYL N (2 METHYLALLYL)TRYPTAMINE; 5 ETHOXY N ETHYL N (2 METHYLALLYL)[ALPHA,ALPHA,BETA,BETA DEXTRO 4]TRYPTAMINE; 5 ETHOXY N ETHYL N ISOPROPYLTRYPTAMINE; 5 ETHOXY N ETHYL N ISOPROPYL[ALPHA,ALPHA,BETA,BETA DEXTRO 4]TRYPTAMINE; 5 ETHOXY N ETHYL N METHYLTRYPTAMINE; 5 ETHOXY N ETHYL N METHYL[ALPHA,ALPHA,BETA,BETA DEXTRO 4]TRYPTAMINE; 5 ETHOXY N ETHYL N PROPYLTRYPTAMINE; 5 ETHOXY N ETHYL N PROPYL[ALPHA,ALPHA,BETA,BETA DEXTRO 4]TRYPTAMINE; 5 ETHOXY N METHYL N ISOPROPYLTRYPTAMINE; 5 ETHOXY N METHYL N ISOPROPYL[ALPHA,ALPHA,BETA,BETA DEXTRO 4]TRYPTAMINE; 5 ETHOXY N METHYL N PROPYLTRYPTAMINE; 5 ETHOXY N METHYL N PROPYL[ALPHA,ALPHA,BETA,BETA DEXTRO 4]TRYPTAMINE; 5 ETHOXY N,N DIALLYLTRYPTAMINE; 5 ETHOXY N,N DIALLYL[ALPHA,ALPHA,BETA,BETA DEXTRO 4]TRYPTAMINE; 5 ETHOXY N,N DIETHYLTRYPTAMINE; 5 ETHOXY N,N DIETHYL[ALPHA,ALPHA,BETA,BETA DEXTRO 4]TRYPTAMINE; 5 ETHOXY N,N DIISOPROPYLTRYPTAMINE; 5 ETHOXY N,N DIISOPROPYL[ALPHA,ALPHA,BETA,BETA DEXTRO 4]TRYPTAMINE; 5 ETHOXY N,N DIMETHYLTRYPTAMINE; 5 ETHOXY N,N DIMETHYL[ALPHA,ALPHA,BETA,BETA DEXTRO 4]TRYPTAMINE; 5 ETHOXY N,N DIPROPYLTRYPTAMINE; 5 ETHOXY N,N DIPROPYL[ALPHA,ALPHA,BETA,BETA DEXTRO 4]TRYPTAMINE; TETRAHYDROFURAN; TRYPTAMINE DERIVATIVE; UNCLASSIFIED DRUG;

ALKYLATION; ARTICLE; DRUG SYNTHESIS; ELECTROSPRAY MASS SPECTROMETRY; FRAGMENTATION REACTION; ION TRAP MASS SPECTROMETRY; MASS FRAGMENTOGRAPHY; MICROWAVE RADIATION; NUCLEAR MAGNETIC RESONANCE SPECTROSCOPY; PRIORITY JOURNAL; REDUCTION; TEMPERATURE;

EID: 80053391539     PISSN: 19427603     EISSN: 19427611     Source Type: Journal    
DOI: 10.1002/dta.223     Document Type: Article

References (45)

1. A. Slassi, M. Isaac, A. O'Brien, Expert Opin. Ther. Patents 2002, 12, 513.
2. E. S. Mitchell, B. J. Hoplight, S. P. Lear, J. F. Neumaier, Neuropharmacology 2006, 50, 412.
3. J. Holenz, P. J. Pauwels, J. L. Diaz, R. Merce, X. Codony, H. Buschmann, Drug Discov. Today 2006, 11, 283.
4. D. J. Heal, S. L. Smith, A. Fisas, X. Codony, H. Buschmann, Pharmacol. Ther. 2008, 117, 207.
5. K. G. Liu, A. J. Robichaud, Drug Dev. Res. 2009, 70, 145.
6. R. A. Glennon, U. Siripurapu, B. L. Roth, R. Kolanos, M. L. Bondarev, D. Sikazwe, M. Lee, M. Dukat, Curr. Top. Med. Chem. 2010, 10, 579.
7. R. E. Schultes, A. Hofmann, Plants of the Gods: Their Sacred, Healing and Hallucinogenic Powers, McGraw-Hill: New York, 1979.
8. C. Rätsch, The Encyclopedia of Psychoactive Plants: Ethnopharmacology and its Applications, Park Street Press: Rochester, VT, 2005.
9. R. R. Griffiths, W. A. Richards, U. McCann, R. Jesse, Psychopharmacology 2006, 187, 268.
10. R. Griffiths, W. Richards, M. Johnson, U. McCann, R. Jesse, J. Psychopharmacol. 2008, 22, 621.
11. S. Roe, Home Office Statistical Bulletin 2005, Available at: [19 September 2010].
12. A. P. Sempere, L. Berenguer-Ruiz, F. Almazán, Rev. Neurol. 2006, 43, 571.
13. R. A. Sewell, J. H. Halpern, G. P. Harrison, Neurology 2006, 66, 1920.
14. F. A. Moreno, C. B. Wiegand, E. K. Taitano, P. L. Delgado, J. Clin. Psychiat. 2006, 67, 1735.
15. F. X. Vollenweider, M. Kometer, Nat. Rev. Neurosci. 2010, 11, 642.
16. F. Nagai, R. Nonaka, K. Satoh Hisashi Kamimura, Eur. J. Pharmacol. 2007, 559, 132.
17. T. S. Ray, PLoS One 2010, 5, e9019.
18. A. T. Shulgin, A. Shulgin, TIHKAL: The Continuation, Transform Press: Berkeley, USA, 1997.
19. A. T. Shulgin, Basic pharmacology and effects. In Hallucinogens. A Forensic Drug Handbook, Chapter 3. (Ed: R. R. Laing ), Elsevier Science Ltd: London, 2003, pp. 67.
20. W. E. Fantegrossi, K. S. Murnane, C. J. Reissig, Biochem. Pharmacol. 2008, 75, 17.
21. J. C. Winter, Psychopharmacology 2009, 203, 251.
22. N. V. Cozzi, A. Gopalakrishnan, L. L. Anderson, J. T. Feih, A. T. Shulgin, P. F. Daley, A. E. Ruoho, J. Neural Transm. 2009, 116, 1591.
23. D. Fontanilla, M. Johannessen, A. R. Hajipour, N. V. Cozzi, M. B. Jackson, A. E. Ruoho, Science 2009, 323, 934.
24. D. E. Nichols, Pharmacol. Ther. 2004, 101, 131.
25. R. Pon, Can. Soc. Forensic Sci. J. 2008, 41, 165.
26. E. Tanaka, T. Kamata, M. Katagi, H. Tsuchihashi, K. Honda, Forensic Sci. Int. 2006, 163, 152.
27. G. Alatrash, N. S. Majhail, J. C. Pile, Mayo Clin. Proc. 2006, 81, 550.
28. A. Ikeda, K. Sekiguchi, K. Fujita, H. Yamadera, Y. Koga, Am. J. Psychiat. 2005, 162, 815.
29. R. Meatherall, P. Sharma, J. Anal. Toxicol. 2003, 27, 313.
30. S. P. Vorce, J. H. Sklerov, J. Anal. Toxicol. 2004, 28, 407.
31. J. A. Wilson, F. McGeorge, S. Smolinske, R. Meatherall, Forensic Sci. Int. 2005, 148, 31.
32. S. A. Barker, M. A. Littlefield-Chabaud, C. David, J. Chromatogr. B 2001, 751, 37.
33. E. H. McIlhenny, K. E. Pipkin, L. J. Standish, H. A. Wechkin, R. Strassman, S. A. Barker, J. Chromatogr. A 2009, 1216, 8960.
34. M. E. Speeter, W. C. Anthony, J. Am. Chem. Soc. 1954, 76, 6208.
35. S. D. Brandt, S. Freeman, I. A. Fleet, P. McGagh, J. F. Alder, Analyst 2005, 130, 330.
36. D. Mansell, S. Brandt, S. Nasima, N. Turvey, J. Alder, S. Freeman, C. Schwalbe, Spectrosc. Lett. 2009, 42, 156.
37. G. J. Shaw, G. J. Wright, G. W. A. Milne, Biomed. Mass Spectrom. 1977, 4, 348.
38. T. Hesselgren, O. Beck, J. Label. Compd. Radiopharm. 1980, 17, 411.
39. P. E. Morris, C. Chiao, J. Label. Compd. Radiopharm. 1993, 33, 455.
40. Y. Z. Xu, C. Chen, J. Label. Compd. Radiopharm. 2006, 49, 897.
41. Y. Y. Wang, C. P. Chen, J. Chin. Chem. Soc. 2007, 54, 1363.
42. Y. Y. Wang, C. P. Chen, J. Label. Compd. Radiopharm. 2007, 50, 1262.
43. O. Beck, G. Sedvall, J. Label. Compd. 1975, 11, 57.
44. S. D. Brandt, S. S. Tirunarayanapuram, S. Freeman, N. Dempster, S. A. Barker, P. F. Daley, N. V. Cozzi, C. P. B. Martins, J. Label. Compd. Radiopharm. 2008, 51, 423.
45. S. D. Brandt, S. Freeman, I. A. Fleet, J. F. Alder, Analyst 2005, 130, 1258.